Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Ruukki Construction completes major investment in Finland: more sustainable roofs more efficiently

Ruukki ConstructionPress release15 November 2024 at 9 am EETRuukki Construction, part of SSAB, is today celebrating the opening of the new roof profile production line in Vimpeli, Finland. The production line for Ruukki Classic®, Ruukki Classic® LowCarbon and Ruukki® Trendic profiles is the largest single machine investment in the project announced in December 2021. The improvements will result in new, better and more sustainable roofing products more efficiently for Ruukki's installation partners as well as for house builders and renovators. In Scandinavia, the residential roofing

Esmaeilzadeh Holding publishes net asset value as of 31 October 2024

As of 31 October 2024, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 6.52 billion (SEK 6.54 billion as of 30 September 2024), corresponding to a net asset value per share of SEK 8,301 (SEK 8,332 as of 30 September 2024).[1]  For further information, please contact: Mikael Ericson, CEO mikael.ericson@ehab.group For press related enquires, please contact: Michaela Abercrombie Simpson, Head of Communications Phone: +46 736 301 403 The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on 15

Gradientech presented QuickMIC® performance data at the 17th National Microbiology Conference in Romania

The diagnostics company Gradientech announces the presentation of newly published outstanding performance data on QuickMIC® at the 17th National Conference of Microbiology and Epidemiology in Iași, Romania, 7-9 November 2024.The national conference in Iași brought together experts in infectious diseases and clinical microbiology from across Romania to discuss urgent public health challenges. The sessions addressed various topics, including innovative diagnostics and infection prevention strategies. The QuickMIC® system was showcased by Biomedica Medizinprodukte GmbH, Gradientech’s

Orthex Corporation: Interim Report January–September 2024

Orthex Corporation, Stock exchange release, 15 November 2024 at 9.00 a.m. EETStrong sales growth outside the Nordics, higher costs affected profitability This release is a summary of Orthex Corporation’s Interim Report for the period January–September 2024. The complete report is attached to this release as a pdf-file. It is also available on Orthex’s website at https://investors.orthexgroup.com/.July–September 2024 · Invoiced sales amounted to EUR 23.3 million (22.2) · Net sales increased by 4.2% to EUR 22.8 million (21.9) · Adjusted EBITDA was EUR 4.0 million (4.5) ·

Peab builds plant for critical minerals in Luleå

Peab has been commissioned to build LKAB's demonstration plant for critical minerals in Luleå. LKAB will verify the process for refining phosphorus and rare earth elements at the plant. The contract is worth SEK 118 million.LKAB is planning to build an industrial park for critical minerals in Luleå. At this plant critical minerals will be extracted from what is currently mining waste from LKAB's iron ore production. This includes producing phosphorus and rare earth elements that are needed, for example, in agriculture, electric car production and wind turbines. Peab will build LKAB's

Capnor Weasel Bidco Oyj, Interim Report January – September 2024

Interim Report for the third quarter of 2024 Third quarter highlights · Revenue increased by 21% to MEUR 27.8 (22.9) · Adjusted EBITDA decreased by 4% to MEUR 2.5 (2.6), corresponding to a 9% (11%) EBITDA margin · Adjusted EBIT decreased to MEUR -0.7 (0.0), corresponding to a -2% (0%) EBIT margin · Operational Cash Flow improved to MEUR 1.1 from MEUR -3.6 in the previous year Significant events during the quarter · iLOQ signed a global framework agreement with leading European residential real estate company, Heimstaden Bostad with a portfolio of approximately 160,

The last day of trading with the warrants of series TO5 in PEPTONIC medical AB is today, November 15, 2024

NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, JAPAN, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SOUTH KOREA, CANADA, OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE FURTHER ACTIONS BEYOND THOSE REQUIRED BY SWEDISH LAW. Today, November 15, 2024, is the last day of trading with the warrants of series TO5 (“TO5”) in PEPTONIC medical AB (“Peptonic” or the “Company”). The exercise period for TO5 runs up to and including November 20, 2024. Each TO5 gives the owner the right to

K-Fast Holding AB’s Nomination committee for the 2025 Annual General Meeting

The Nomination committee for the 2025 Annual General Meeting of K-Fast Holding AB (publ) has been appointed. According to the instructions for the Nomination committee adopted at K-Fast Holding AB (publ)’s Extraordinary General Meeting on 19 August 2019, the Nomination committee shall consist of four members representing the three largest shareholders in terms of number of votes as of 30 September, together with the Chairman of the Board. If a shareholder, who is entitled to appoint a representative to the Nomination committee, abstains from appointing a representative, the right to

Genetic Analysis AS: Interim report January – September 2024

OSLO, NORWAY – 15 November 2024: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the third quarter and the first nine months of 2024. The interim report is available as an attached file to this release and on the Company's website. Below is a summary of the report.Ronny Hermansen, CEO of Genetic Analysis, comments:“I am pleased to announce that, although sales are usually slower during the summer, GA has been very productive in several areas to improve our product offering and complete important cost efficiency implementations. Our

Metso's financial reporting and Annual General Meeting in 2025

Metso Corporation’s stock exchange release on November 15, 2024, at 09:00 a.m. EETMetso Corporation will publish its financial reports in 2025 as follows: · Financial Statements Review for 2024 on February 13, 2025 · Annual Report for 2024 during the week of March 24, 2025 · Interim Report for January - March 2025 on April 24, 2025 · Half-Year Financial Report for January - June 2025 on July 23, 2025 · Interim Report for January – September 2025 on October 23, 2025 The Annual General Meeting is planned to be held on April 24, 2025. Metso’s Board of Directors will convene

Delårsrapport

1 JANUARI – 30 SEPTEMBER 2024FLOWSCAPE TECHNOLOGY AB (publ),ORG.Nr. 556725-4866 Styrelsen och verkställande direktören för Flowscape Technology AB avger härmed rapport för perioden januari – september 2024. Belopp anges i tusentals kronor. Siffror inom parentes avser motsvarande period föregående år This information is only available in SwedishJanuari – september i korthet, koncern Tredje kvartalet (Juli-september) · Nettoomsättningen uppgick till 11 135 (11 000) TSEK · Rörelseresultat före avskrivningar uppgick till 2 543 (250) TSEK · Resultat efter finansiella

Implantica publishes Interim Report January – September 2024 (Q3)

RefluxStop™ achieves crucial FDA milestone and leaps forward with strong momentum in both the US and EuropeSignificant events in the third quarter of 2024 · First national RefluxStop™ user meetings took place in Italy and Spain with over 40 leading surgeons attending – just 1.5 years after market entry in these countries · Expansion in the UK NHS public hospital network continues with Chelsea & Westminster Hospital in London joining the RefluxStop™ centers · 4-year results from our CE-mark study published in Surgical Endoscopy showcasing continued excellent results up until 4-

Kemira plans to build a re-activation plant for activated carbon – the pre-engineering phase is ongoing

Kemira Oyj, Press Release, November 15, 2024 at 9.00 am EETKemira plans to build a re-activation plant for activated carbon – the pre-engineering phase is ongoing Kemira plans to expand its Helsingborg manufacturing site in Sweden and to invest low double-digit millions of euros in building a reactivation plant for activated carbon. The new plant would add significant new capacity to reactivate activated carbon for the Nordic drinking water and wastewater market. The expansion project plans are a part of Kemira’s long-term strategy to double its water treatment business. The pre-

CapMan Infra invests in heat-as-a-service operator and bioenergy producer ProPellet

CapMan Infra press release15 November 2024 at 09:00 AM EET CapMan Infra invests in heat-as-a-service operator and bioenergy producer ProPellet CapMan Nordic Infrastructure II fund invests in ProPellet, a heat-as-a-service (“HaaS”) operator and bioenergy producer. The company offers property-specific HaaS solutions and operates its own pellet fuel production facilities. CapMan Infra aims to support the company's growth by financing investments in the HaaS operations and expansion into new customer groups and energy technologies. CapMan Infra has agreed to acquire a majority stake

Safello publishes interim report for the third quarter 2024 and momentum is building for Safello

Stockholm, 15 November, 2024 | Today, Safello Group AB (“Safello”) publishes the company’s interim report for the third quarter (1 July–30 September) 2024. The report is attached hereto and can be found on  https://safello.com/investors/reports. Summary of the third quarter (Jul-Sep 2024) · Net turnover increased by 25 % and amounted to SEK 143.2 million (115.0). · Gross profit increased by 27 % and amounted to SEK 9.3 million (7.3) · Operating profit/loss before depreciation and amortization (EBITDA) amounted to SEK -0.4 million (-1.

Office space totaling 1,500 square meters let in central Gothenburg

Wallenstam has recently completed several office lettings in central Gothenburg, which is filling the city’s attractive locations with new, dynamic businesses. Approximately 1,500 square meters of office space in inner city locations has recently been let to companies with specialist expertise in IT, digital marketing, streetwear and psychology.Some of the popular addresses include, for example Avenyn, Kungsgatan, Södra Hamngatan, Södra Larmgatan and Vallgatan.“The interest and demand for prime office premises in good city locations is stable. Proximity to lively city life and flexible

SCA appoints a new head for the Containerboard and Pulp business areas

SCA appoints Petteri Kalela as the new head of the Containerboard and Pulp business areas and member of the executive management team.SCA has recruited Petteri Kalela as the new President of business areas Containerboard and Pulp and member of the executive management team. Kalela has extensive experience in the forest industry and has held several business leadership roles in Europe and Asia. "Petteri Kalela will be a valuable addition to SCA's executive management team and as head of the Containerboard and Pulp business areas. We look forward to welcoming him in the first half of 2025",

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 November 2024 at 9:00 EETDuring the 1 October – 31 October 2024 conversion period there were seven conversions and a total of 102,764 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 November 2024, and trading in the new R shares will start on 18 November 2024.Breakdown of shares after conversion:A shares     175,726,507R shares     612,893,480Total           788,619,987Each A share and every ten R shares carry one vote. The total amount of votes after the conversion is at least 237,015,

There are no items matching the current filter
There are no more items matching the current filter
Back to top